Platinum-based compounds are the most widely used anticancer drugs but, their elevated toxicity and chemoresistance has stimulated the study of others, such as ruthenium-based compounds. NAMI-A and UNICAM-1 were tested in vitro, comparing the mechanisms of toxicity, in terms of mitochondrial functionality and cellular oxidative stress. UNICAM-1, showed a clear mitochondrial target and a cytotoxic dose-dependent response thanks to its ability to promote an imbalance of cellular redox status. It impaired directly mitochondrial respiratory chain, promoting mitochondrial superoxide anion production, leading to mitochondrial membrane depolarization. All these aspects, could make UNICAM-1 a valid alternative for chemotherapy treatment of breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mito.2020.11.004DOI Listing

Publication Analysis

Top Keywords

mitochondrial functionality
8
oxidative stress
8
breast cancer
8
mitochondrial
6
evaluation anticancer
4
anticancer role
4
role novel
4
novel rutheniumii-based
4
rutheniumii-based compound
4
compound compared
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!